Short Interest in Ipsen S.A. (OTCMKTS:IPSEY) Expands By 80.0% – Defense World

Ipsen S.A. (OTCMKTS:IPSEY Get Rating) was the target of a significant growth in short interest in the month of May. As of May 31st, there was short interest totalling 900 shares, a growth of 80.0% from the May 15th total of 500 shares. Based on an average trading volume of 1,200 shares, the days-to-cover ratio is presently 0.8 days.

Shares of IPSEY opened at $24.14 on Monday. The stock has a 50 day moving average price of $27.14 and a two-hundred day moving average price of $26.50. Ipsen has a 52 week low of $21.71 and a 52 week high of $32.51.

The business also recently disclosed a dividend, which was paid on Thursday, June 9th. Shareholders of record on Wednesday, June 1st were issued a dividend of $0.2269 per share. This represents a yield of 0.88%. The ex-dividend date was Tuesday, May 31st.

About Ipsen (Get Rating)

Ipsen SA operates as a biopharmaceutical company worldwide. The company provides drugs in the areas of oncology, neuroscience, gastroenterology, cognitive disorders, and rare diseases. It offers Somatuline for neuroendocrine tumors and acromegaly; Decapeptyl for the treatment of advanced metastatic prostate cancer; Cabometyx for renal cell and second-line hepatocellular carcinoma; Onivyde for second-line metastatic pancreatic cancer; Dysport for motor muscular disorders and medical aesthetics; NutropinAq for growth failure in children due to growth hormone (GH) deficiency, turner syndrome, chronic renal failure, and GH deficiency in adults; and Increlex for growth failure in children and adolescents.

Featured Articles

Receive News & Ratings for Ipsen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ipsen and related companies with MarketBeat.com's FREE daily email newsletter.

More:

Short Interest in Ipsen S.A. (OTCMKTS:IPSEY) Expands By 80.0% - Defense World